Peer Review History
| Original SubmissionOctober 13, 2025 |
|---|
|
Dear Dr. Fan, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 01 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Shih-Chao Lin, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 3. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Along with many articles published recently exploring the roles of intratumoral bacteria in modulating cancer cell physiology, PONE-D-25-55502 presents some novel findings on the importance of dnaK in stimulating the metastatic potential breast cancer cell. This article can be considered for publication after a major revision and points that need to be revised are shown in the following: 1. Improved expression of microfluidic shear stress assay shown in figure 5: Instead of presenting cell viability following a fixed time period (8 h) of laminar flow, a better understanding on the role of dnaK in modulating the metastatic potential of the breast cancer cell line MDA-MB-231 can be achieved using a kinetic presentation of cell viability. It would be good to revise figure 5 by showing how the survival rates of uninfected cancer cells and cells infected with wild-type, dnak-mutant and dnak-C strain change according to hour after laminar flow using the viability of uninfected cells at the shortest flow time as the basis for comparison as the resilience of cancer cells to shear stress should change gradually after bacterial infection. 2. Reorganization of abstract: Based on the figures shown in this submission, most readers would not be surprised to know the importance of dnak, a bacterial version of Hsp70, in counteracting acid and oxidative stresses. The most valuable data of this submission should be the ability of the dnak of Staphylococcus xylosus to enhance cancer cell viability under shear stress, therefore promoting the metastatic potential of breast cancer cells. Information on this point are poorly revealed in the abstract of the original submission and they need to be emphasized in the revised abstract while reducing the text that describe information not very surprising to the readers. 3. Title change: --mechanical resilience to breast tumor cells should change to-- mechanical resilience to a human breast cancer cell line as a human breast cancer line, not a whole tumor model, was used for studying the influence of intratumoral bacteria on tumor metastatic potential. 4. The source of wild-type Staphylococcus xylosus: It should be made clear who actually isolated this strain from human breast tumor. Was the bacterial strain provided by the authors contributing reference 11 as shown in materials and methods? or isolated by the authors of PONE-D-25-55502 themselves as shown in Table 1 because it says “this study”? 5. Which is the correct term ? DnaK or dnaK? Reviewer #2: The manuscript presents interesting findings regarding the role of DnaK in Staphylococcus xylosus intracellular survival and stress adaptation and contribute to mechanical resistance of breast tumor cells using breast cancer cell line MDA-MB-231. The topic is relevant and potentially impactful; however, there are several concerns regarding data interpretation, methodological consistency, and clarity of presentation that should be addressed before considering the manuscript for publication. A. Initial Bacterial Inoculum and Growth Data (Figure 1B & Figure 3A): In Figure 1B, the authors report an initial bacterial density of approximately 1 × 10⁸ CFU/mL corresponding to an OD₆₀₀ of 0.05. The 1 × 10⁸ CFU/mL typically aligns with OD₆₀₀ values of 0.08–0.1 (equivalent to 0.5 McFarland). The reported data therefore appear inconsistent and should be clarified. Additionally, the increase in bacterial count shown in Figure 1B reflects only about a one-log increase, which seems minimal and raises questions about the growth phase or conditions used during the experiment. In Figure 3A, the starting OD₆₀₀ is reported to be around 0.15, equivalent to approximately 1 × 10⁸ CFU/mL which is not consistent with the inoculum in Figure 1B at OD 600 0.05. The authors should clarify why different starting concentrations were used and whether this variation could affect the observed growth trends. B. Invasion and Intracellular Survival Assays (Figure 2): The invasion assay results (Figure 2C) indicate that all tested strains have comparable intracellular entry levels, suggesting DnaK is not required for host cell invasion. However, Figure 2D shows that the ΔDnaK mutant exhibits significantly reduced intracellular survival approximately a threefold decrease relative to the wild type. It is not clear how the assay differentiates between the intracellular level in the invasion assay and that for intracellular survival. Moreover, the authors conclude that DnaK is specifically required for long-term intracellular persistence but not for host cell entry. This interpretation may be premature, given that the post infection incubation time is only 2 hours. Two hours may reflect early post-entry survival rather than long-term persistence. C. Role of DnaK and Potential Effects on Host Cells: The DnaK can modulate host cell proteins such as PARP1 and p53, which are essential for maintaining genomic integrity. Given this, it is probable that the presence or absence of DnaK could influence host cell viability or response, thereby indirectly affecting bacterial intracellular survival. The authors should discuss this possibility and consider whether observed differences might partly result from altered host cell physiology rather than direct bacterial adaptation. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Todd Hsu Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
<p>DnaK Supports Intracellular Persistence of Staphylococcus xylosus and Confers Mechanical Resilience to a Human Breast Cancer Cell Line PONE-D-25-55502R1 Dear Dr. Fan, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Shih-Chao Lin, Ph.D. Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: All necessary revisions of title, source of bacteria, and most importantly a time-course monitoring of the viability of cancer cells infected by wild-type and mutant Staphylococcus xylosus against mechanical shear force have been made. Hence, PONE-D-25-55502R1 can be accepted for publication. Reviewer #2: The authors have revised the manuscript and made the required amendments and have adequately addressed all raised comments ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Todd Hsu Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-55502R1 PLOS One Dear Dr. Fan, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Shih-Chao Lin Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .